Cryptococcosis—a systematic review to inform the World Health Organization Fungal Priority Pathogens List
Medical Mycology · 27.06.2024 · 62 (6)
DOI: 10.1093/mmy/myae043 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Medical Mycology, online erschienen am 27.06.2024. Verfasst von Aiken Dao und 14 weiteren Autor:innen. Beteiligte Einrichtung: Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Cryptococcosis, Antifungal Agents, Cryptococcus gattii, Cryptococcus neoformans. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 106 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: World Health Organization, NIAID NIH HHS, Ministry of Education and Science.
Abstract (Originalsprache)
Cryptococcosis causes a high burden of disease worldwide. This systematic review summarizes the literature on Cryptococcus neoformans and C. gattii infections to inform the World Health Organization’s first Fungal Priority Pathogen List. PubMed and Web of Science were used to identify studies reporting on annual incidence, mortality, morbidity, antifungal resistance, preventability, and distribution/emergence in the past 10 years. Mortality rates due to C. neoformans were 41%–61%. Complications included acute renal impairment, raised intracranial pressure needing shunts, and blindness. There was moderate evidence of reduced susceptibility (MIC range 16–32 mg/l) of C. neoformans to fluconazole, itraconazole, ketoconazole, voriconazole, and amphotericin B. Cryptococcus gattii infections comprised 11%–33% of all cases of invasive cryptococcosis globally. The mortality rates were 10%–23% for central nervous system (CNS) and pulmonary infections, and ∼43% for bloodstream infections. Complications described included neurological sequelae (17%–27% in C. gattii infections) and immune reconstitution inflammatory syndrome. MICs were generally low for amphotericin B (MICs: 0.25–0.5 mg/l), 5-flucytosine (MIC range: 0.5–2 mg/l), itraconazole, posaconazole, and voriconazole (MIC range: 0.06–0.5 mg/l). There is a need for increased surveillance of disease phenotype and outcome, long-term disability, and drug susceptibility to inform robust estimates of disease burden.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Sydney Infectious Diseases Institute, The University of Sydney, Sydney, Australia.
- Westmead Institute for Medical Research, Westmead, Sydney, Australia.
- Westmead Clinical School, Westmead Hospital, Sydney, Australia.
- Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
- Department of Pharmacy, Westmead Hospital, Westmead, Australia.
- Sunshine Coast University Hospital, Birtinya, Qld 4575, Australia.
ORCID-Profile: Aiken Dao, Sarah Kidd, Tania C Sorrell, Ana Alastruey-Izquierdo, Jan-Willem Alffenaar, Sharon C-A Chen, Justin Beardsley
Förderung
- World Health Organization
- NIAID NIH HHS
- Ministry of Education and Science
Zitieren
APA
Dao, A., Kim, H. Y., Garnham, K., Kidd, S., Sati, H., Perfect, J., Sorrell, T. C., Harrison, T., Rickerts, V., Gigante, V., Alastruey-Izquierdo, A., Alffenaar, J. W., Morrissey, C. O., Chen, S. C., & Beardsley, J. (2024). Cryptococcosis—a systematic review to inform the World Health Organization Fungal Priority Pathogens List. Medical Mycology, 62(6). https://doi.org/10.1093/mmy/myae043
Vancouver
Dao A, Kim HY, Garnham K, Kidd S, Sati H, Perfect J, et al. Cryptococcosis—a systematic review to inform the World Health Organization Fungal Priority Pathogens List. Medical Mycology. 2024;62(6). doi:10.1093/mmy/myae043
BibTeX
@article{Dao2024,
author = {Dao, Aiken and Kim, Hannah Yejin and Garnham, Katherine and Kidd, Sarah and Sati, Hatim and Perfect, John and Sorrell, Tania C and Harrison, Thomas and Rickerts, Volker and Gigante, Valeria and Alastruey-Izquierdo, Ana and Alffenaar, Jan-Willem and Morrissey, C Orla and Chen, Sharon C-A and Beardsley, Justin},
title = {Cryptococcosis—a systematic review to inform the World Health Organization Fungal Priority Pathogens List},
journal = {Medical Mycology},
year = {2024},
volume = {62},
number = {6},
doi = {10.1093/mmy/myae043}
}
EUVIMED